Progressive systemic sclerosis is a connective tissue disease. Its maj
or hallmarks are uncontrolled and irreversible proliferation of connec
tive tissue. vascular lesions as well as autoimmunologic factors. PSS
is clinically devided into 2 different courses. PSS type ZI is charact
erized by a rapid progressive course where visceral participation occu
rs relatively early. Autopsy studies suggest that 60 - 80% of patients
with scleroderma have renal involvement. Most patients present in the
cooler months, suggesting a contributory, role of cold-induced vasosp
asm which might exacerbate renal ischemia and hypersecretion of renin.
Scleroderma renal crisis develops in 10 - 15% of cases. The renal cri
sis is associated with abrupt onset of marked hypertension and renal f
ailure. The primary histologic changes in the kidney affect the interl
obular arteries, the glomeruli, and the interstitium. Therapy is most
likely to be effective if initiated early before marked and often irre
versible morphologic alterations have occurred. Because of that, follo
wing and monitoring particularly those patients: with rapid skin invol
vement during the first 5 years of scleroderma is recommended. Treatme
nt of hypertension is the mainstay of therapy in scleroderma renal cri
sis. An angiotensin converting enzyme (ACE) inhibitor is the agent of
choice. When compared to other antihypertensive agents, ACE inhibitors
have increased antihypertensive efficacy, appear to be associated wit
h improved survival, and lead to better preservation of renal function
. Hermodialysis may become necessary. In some patients considerable re
covery of renal function, which may permit the discontinuation of dial
ysis, is observed, Therefore, any decisions regarding renal transplant
ation should not be made during or shortly after the acute episode, Es
sential sentence. Renal crisis develops in 10 - 20% of cases with rapi
d progressive course of PSS. Aggressive treatment of hypertension with
an ACE inhibitor as the agent of choice can stabilize anal function a
nd improve survival.